ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
HeartSciences Inc

HeartSciences Inc (HSCS)

3.2277
-0.0723
(-2.19%)
終了 2月1日 6:00AM
3.2277
0.00
(0.00%)
取引時間後: 9:41AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
3.2277
買値
3.22
売値
3.64
出来高
6,234
3.1399 日の範囲 3.30
2.36 52 週間の範囲 18.50
時価総額
前日終値
3.30
始値
3.30
時刻
1
@
3.47
最終取引時間
財務取引量
US$ 19,971
VWAP
3.2036
平均取引量 (3 か月)
35,017
発行済株式数
980,321
配当利回り
-
PER
-0.48
1 株当たり利益 (EPS)
-6.74
歳入
19k
純利益
-6.61M

HeartSciences Inc について

Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-o... Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. 詳細を表示

セクター
Ortho,prosth,surg Appl,suply
業界
Ortho,prosth,surg Appl,suply
ウェブサイト
本社
Southlake, Texas, USA
設立
-
HeartSciences Inc is listed in the Ortho,prosth,surg Appl,suply sector of the ナスダック市場 with ticker HSCS. The last closing price for HeartSciences was US$3.30. Over the last year, HeartSciences shares have traded in a share price range of US$ 2.36 to US$ 18.50.

HeartSciences currently has 980,321 shares in issue. The market capitalisation of HeartSciences is US$3.24 million. HeartSciences has a price to earnings ratio (PE ratio) of -0.48.

HSCS 最新ニュース

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company...

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Southlake, TX, July 29, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Southlake, TX, July 25, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Southlake, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Regains Compliance with Nasdaq Listing Requirements

Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.2223-6.443478260873.453.47923.18145893.3006624CS
4-0.4636-12.5592609653.69133.883.1148143.4083617CS
120.457716.5234657042.774.69022.5164350173.55400012CS
26-0.5823-15.28346456693.815.29892.361976824.02299687CS
52-10.1723-75.912686567213.418.52.3685427210.55710714CS
156-371.7723-99.139283756002.36168973477.2353799CS
260-371.7723-99.139283756002.36168973477.2353799CS

HSCS - Frequently Asked Questions (FAQ)

What is the current HeartSciences share price?
The current share price of HeartSciences is US$ 3.2277
How many HeartSciences shares are in issue?
HeartSciences has 980,321 shares in issue
What is the market cap of HeartSciences?
The market capitalisation of HeartSciences is USD 3.24M
What is the 1 year trading range for HeartSciences share price?
HeartSciences has traded in the range of US$ 2.36 to US$ 18.50 during the past year
What is the PE ratio of HeartSciences?
The price to earnings ratio of HeartSciences is -0.48
What is the cash to sales ratio of HeartSciences?
The cash to sales ratio of HeartSciences is 166.49
What is the reporting currency for HeartSciences?
HeartSciences reports financial results in USD
What is the latest annual turnover for HeartSciences?
The latest annual turnover of HeartSciences is USD 19k
What is the latest annual profit for HeartSciences?
The latest annual profit of HeartSciences is USD -6.61M
What is the registered address of HeartSciences?
The registered address for HeartSciences is 550 RESERVE ST, SUITE 360, SOUTHLAKE, TEXAS, 76092
What is the HeartSciences website address?
The website address for HeartSciences is www.heartsciences.com
Which industry sector does HeartSciences operate in?
HeartSciences operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.71M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.82M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.39M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.57M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.8M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.89k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
872.26k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.27M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
731.1M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.5M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
341.8M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
237.15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.44M

HSCS Discussion

投稿を表示